Capital Planning Advisors’s Zimmer Biomet ZBH Stock Holding History

Capital Planning Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,137	Closed	-$545K	–	111
2015 Q2	$545K	Buy	5,137 +103	+2%	+$11.4K	0.32%	60
2015 Q1	$574K	Hold	5,034	–	–	0.4%	46
2014 Q4	$554K	Buy	+5,034	New	+$531K	0.48%	45

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Capital Planning Advisors's ZBH Position: Q3 2015 in Review

Capital Planning Advisors sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 5,137 shares — an estimated $545K sold.

Capital Planning Advisors first reported a position in ZBH in Q4 2014 and held it in 3 quarters. The position peaked at $574K in Q1 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Capital Planning Advisors reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Capital Planning Advisors sold 5,137 Zimmer Biomet shares in Q3 2015, an estimated $545K.
Capital Planning Advisors first reported a position in Zimmer Biomet in Q4 2014 and held it in 3 quarters.
Capital Planning Advisors's Zimmer Biomet position peaked at $574K in Q1 2015.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Capital Planning Advisors's 13F filing for Q3 2015, filed 20 Oct 2015.